The possibility of protecting women against rhesus immunization by the administration of anti-D immunoglobulin shortly after delivery has lately received considerable attention. The combined results of several recent clinical trials with this form of treatment have been summarized by Clarke (1967): of 628 women who received prophylactic treatment only one developed rhesus antibodies, whereas 75 cases of immunization were found among 599 women in the control group.
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It has been shown that rhesus immunization is generally caused by small amounts (less than 1 ml.) of foetal blood that enter the maternal circulation during labour. Rarely, however, very large foeto-maternal haemorrhages occur, and it is important to know if anti-D immunoglobulin prophylaxis is also effective in these cases. Only one case has been described in which a woman with a large transplacental haemorrhage was treated, and in that instance no immunization occurred.
While conducting a clinical trial on the effect of anti-D immunoglobulin prophylaxis in Holland we found two cases of massive foeto-maternal hacmorrhage, while two other cases were referred to us for investigation because the child was anaemic at birth. All four women were treated with anti-D immunoglobulin shortly after delivery. Despite this treatment, all four mothers developed rhesus antibodies. The Kleihauer, Braun, and Betke (1957) . Cells containing mainly foetal haemoglobin (" typical Hb F cells ") were counted in 50 low-power fields (magnification X 100) ; adult erythrocytes were counted on the same blood film at higher magnification ( x 400).
The amount of foetal blood in the mother's circulation was calculated by the following formula (Kleihauer, 1966) :
Volume of foetal blood (ml.)= 0, Hb F cells X 50. According to this formula a Hb F: adult cell ratio of 1: 1,000 corresponds to a transplacental haemorrhage of 5 ml.
The accuracy of this technique was tested on five samples of adult blood mixed with various amounts of cord blood. These mixtures were sent to us by Professor P. L. Mollison and were counted as unknown samples in our laboratory (see Table I1 . I the child was A Rh-positive. The haemoglobin content of the blood was 8.4 g./100 ml., the reticulocyte count was 6.3%, and a blood film showed 59 normoblasts per 100 leucocytes. Liver and spleen were not enlarged. Table II ). Case 4.
-The blood of a 20-year-old secundigravida, blood group A Rh-negative, was examined at 38 and 39 weeks' gestation and on both occasions was found to contain 3.6% of Hb F cells, corresponding to a transplacental bleeding of 180 ml. At 40 weeks a baby of 2,900 g. was delivered spontaneously. The blood group was A Rhpositive, and the haemoglobin content 12.5 g./100 ml. A few normoblasts were seen on the blood film. Liver and spleen were not enlarged. A maternal blood sample drawn immediately after delivery contained 3.8% Hb F cells. Six hours later the mother was given 250 pg. of anti-D immunoglobulin. During the next six days the number of Hb F cells in the maternal blood was shown not to have decreased. Therefore on the seventh day after delivery a second dose of 250 sig. of anti-D immunoglobulin was given. Six days later the foetal cells had disappeared from the mother's circulation (see Chart). Four months after delivery the maternal serum was found to contain anti-D and anti-C in a titre of 1:16 and I : 8, respectively (see Table II ).
Discussion
Prevention of rhesus immunization by prophylactic treatment with anti-D immunoglobulin appears to be effective in practically all transplacental bleeds of small size. Whether this treatment will prove to be as effective when larger foeto-maternal haemorrhages have occurred remains to be proved. This question is of particular interest because it has been shown that the risk of immunization in bleeds of more than 3 ml. is much greater (50',.'$ than in the more usual small bleeds of less than 0.25 ml. (8%o) (Woodrow and Finn, 1966) .
Haemorrhages of more than 100 ml. can occur, but are very rare. So far only one case has been reported in which anti-D immunoglobulin was given (Gilliver, 1967) . In this woman rhesus immunization did not occur. Unfortunately we have not been able to repeat this experience. Though our four cases were treated with anti-D immunoglobulin shortly after delivery, all four women developed rhesus antibodies. It is most unlikely that these antibodies were passively acquired as a result of the treatment. Not only were the titres higher than those immediately following the anti-D injection, but, also, in three cases there were saline antibodies, a type not found in the immunoglobulin preparation. Furthermore, in Cases I and 4 anti-C antibodies developed along with anti-D.
Possible Reasons for Failure There remain three possible reasons for the failure to protect these women from immunization.
The first is that the anti-D immunoglobulin injection may have come too late. Most transplacental haemorrhages occur at the time of delivery, but in each of our cases there are indications that the bleeding had started earlier. In Case 1 the foetus died five days before delivery, and one may therefore assume that the foetal cells entered the maternal circulation at least five days before the anti-D injection was given. Moreover, it is possible that the haemorrhage occurred as a result of the attempt at amniocentesis two days before death. In Case 2 the amount of foetal blood found in the mother's circulation was approximately equal to the baby's own blood volume; therefore, the bleeding probably occurred gradually and started at least several days before delivery. In Case 3 the baby's lively appearance, together with the marked reticulocytosis, suggests that the blood loss also occurred at least a few days before birth. In Case 4 it was actually demonstrated that 180 ml. of foetal blood was already present in the maternal circulation two weeks before labour.
It is not known how long one can safely permit rhesuspositive cells to circulate in a rhesus-negative person before one has lost the opportunity to prevent immunization. The only information on this point comes from Freda, Gorman, and Pollack (1964) , who found that anti-D when administered 72 hours after the injection of rhesus-positive blood still protected male volunteers from active immunization. The evidence described in our cases suggests that large amounts of foetal blood had already been present for a considerable period of and it is possible that active immunization had started before treatment. In the case described by Gilliver (1967) the bleeding probably occurred not more than 12 hours before delivery, and it may be that the apparent therapeutic success was due to the brief exposure to the antigenic stimulus. An alternative reason for failure to protect these women from active immunization may have been that the doses of anti-D Immunoglobulin were too low in relation to the large amounts of rhesus-positive blood. Disappearance of foetal cells from the circulation took much longer (6 to 15 days) than in most transplacental bleedings, where the foetal red cells are cleared within 24 to 48 hours. In Gilliver's patient a dose of approximately 1,000 jug. was administered (U. C. Woodrow, personal communication) . This is higher than the amount given by us (250-750 pug.), and thus may account for the favourable outcome in his patient. Nevertheless, it should be emphasized thtat despite the high dose of anti-D the clearance of foetal red cells in this case took nine days (Gilliver, 1967) . Freda et al. (1964) have suggested that it is not the accelerated clearance of foetal cells but the actual concentration of free antibody in the plasma which is responsible for the suppression of the primary immune response. In large foeto-maternal haemorrhages a considerable part of the anti-D is probably adsorbed by the foetal cells. It is therefore possible that the final concentration of free antibody was too low to bring about effective suppression. If (Pearlman, 1967) . In humans enhancement of anti-D production has possibly been effected by the injection of serum containing anti-D saline agglutinins (Clarke et al., 1963) . With anti-D immunoglobulin preparations, which contain no IgM antibody, enchantment has never been observed even under conditions when the dose was inadequate to suppress immunization (Freda, Gorman, and Pollack, 1966 ;  P. L. Mollison, personal communication). In our series all four women developed rhesus antibodies. This is at variance with the general impression that after a rhesus-incompatible transfusion only 50% of the recipients are immunized (Mollison, 1967 ).
Conclusion
We think that our therapeutic failure is at least partly related to the timing of the anti-D injection. With respect to this one should bear in mind that most cases of large foetomaternal haemorrhages are probably the result of repetitive bleeds occurring before birth, and that they are discovered only when the diagnosis of anaemia is made in the infant. A foetus having a single massive haemorrhage is not likely to survive, and its macerated condition at birth will preclude recognition of the syndrome, unless the maternal blood is especially examined by means of the Kleihauer technique.
On the basis of the foregoing one should search for massive foeto-maternal haemorrhage in all cases where there has been unexplained intrauterine foetal death, or where the infant is anaemic at birth. Once the diagnosis is established it would seem advisable to try to avoid the high risk of immunization by administering high doses of anti-D immunoglobulin.
Summary
Four cases are presented in which a large transplacental haemorrhage (varying from 140 to 350 ml.) occurred in a rhesus-negative woman carrying a rhesus-positive foetus. Shortly after delivery each mother was treated with anti-D immunoglobulin, which resulted in clearance of the foetal red cells from the circulation within 6 to 15 days. Despite this treatment all four women developed rhesus antibodies. The two most likely reasons for these therapeutic failures are: the interval between the transplacental haemorrhage and the administration of the anti-D immunoglobulin may have been too long, or the dose may have been too low in relation to the magnitude of the bleed.
